Ligand Pharmaceuticals (LGND) EBT (2010 - 2026)
Ligand Pharmaceuticals (LGND) posted EBT of $64.3 million for Q2 2026, up 473.0% from $11.22 million a year earlier.
Powered by 
Analysis
Ligand Pharmaceuticals (LGND) EBT (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBT at Ligand Pharmaceuticals was $237.96 million; for FY2025, it was $158.96 million.
- Annual EBT shows a five-year compound annual growth rate of 161.8% (FY2020 to FY2025).
- In prior years, Ligand Pharmaceuticals' EBT was $2.52 million in FY2024 (-96.0%), $63.66 million in FY2023 (+76.8%), $36.01 million in FY2022 (-50.1%) and $72.21 million in FY2021.
- Quarterly EBT has run from a low of -$65.39 million in Q2 2024 to a high of $141.14 million in Q3 2025 over five years.
- The strongest year-over-year quarter for EBT in the past five years was Q2 2026, with growth of 473.0%; the weakest was Q2 2022, with a decline of 74.0%.
- According to Business Quant data, EBT for the three prior quarters was -$24.26 million (Q1 2026), $56.78 million (Q4 2025) and $141.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 6.75 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 4.28 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -683.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.27 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 2.80 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.77 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -653.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.39 Bn |
| 10 | Ligand Pharmaceuticals | 6.26 Bn | 2.72 Bn | - | 64.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 64.30 Mn |
| Mar 31, 2026 | -24.26 Mn |
| Dec 31, 2025 | 56.78 Mn |
| Sep 30, 2025 | 141.14 Mn |
| Jun 30, 2025 | 11.22 Mn |
| Mar 31, 2025 | -50.18 Mn |
| Dec 31, 2024 | -39.20 Mn |
| Sep 30, 2024 | -6.34 Mn |
| Jun 30, 2024 | -65.39 Mn |
| Mar 31, 2024 | 113.45 Mn |
| Dec 31, 2023 | 17.10 Mn |
| Sep 30, 2023 | -12.14 Mn |
| Jun 30, 2023 | 3.17 Mn |
| Mar 31, 2023 | 55.54 Mn |
| Dec 31, 2022 | 24.14 Mn |
| Sep 30, 2022 | 12.35 Mn |
| Jun 30, 2022 | 8.66 Mn |
| Mar 31, 2022 | -9.14 Mn |
| Dec 31, 2021 | 17.88 Mn |
| Sep 30, 2021 | 15.26 Mn |
API Access
Ligand Pharmaceuticals EBT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt&ticker=LGND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt", "ticker": "LGND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt&ticker=LGND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();